Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]Code Context
trigger_error($message, E_USER_DEPRECATED);
}
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.' $stackFrame = (int) 1 $trace = [ (int) 0 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php', 'line' => (int) 2421, 'function' => 'deprecationWarning', 'args' => [ (int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.' ] ], (int) 1 => [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 73, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) {}, 'type' => '->', 'args' => [ (int) 0 => 'catslug' ] ], (int) 2 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php', 'line' => (int) 610, 'function' => 'printArticle', 'class' => 'App\Controller\ArtileDetailController', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 3 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 120, 'function' => 'invokeAction', 'class' => 'Cake\Controller\Controller', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 4 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 94, 'function' => '_invoke', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(App\Controller\ArtileDetailController) {} ] ], (int) 5 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php', 'line' => (int) 235, 'function' => 'dispatch', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 6 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Http\BaseApplication', 'object' => object(App\Application) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 7 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php', 'line' => (int) 162, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 8 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\RoutingMiddleware', 'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 9 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php', 'line' => (int) 88, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 10 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\AssetMiddleware', 'object' => object(Cake\Routing\Middleware\AssetMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 11 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php', 'line' => (int) 96, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 12 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware', 'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 13 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 51, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 14 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php', 'line' => (int) 98, 'function' => 'run', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\MiddlewareQueue) {}, (int) 1 => object(Cake\Http\ServerRequest) {}, (int) 2 => object(Cake\Http\Response) {} ] ], (int) 15 => [ 'file' => '/home/brlfuser/public_html/webroot/index.php', 'line' => (int) 39, 'function' => 'run', 'class' => 'Cake\Http\Server', 'object' => object(Cake\Http\Server) {}, 'type' => '->', 'args' => [] ] ] $frame = [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 73, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) { trustProxy => false [protected] params => [ [maximum depth reached] ] [protected] data => [[maximum depth reached]] [protected] query => [[maximum depth reached]] [protected] cookies => [ [maximum depth reached] ] [protected] _environment => [ [maximum depth reached] ] [protected] url => 'latest-news-updates/northeast-hiv-tests-hit-by-reagent-hurdle-gs-mudur-21891/print' [protected] base => '' [protected] webroot => '/' [protected] here => '/latest-news-updates/northeast-hiv-tests-hit-by-reagent-hurdle-gs-mudur-21891/print' [protected] trustedProxies => [[maximum depth reached]] [protected] _input => null [protected] _detectors => [ [maximum depth reached] ] [protected] _detectorCache => [ [maximum depth reached] ] [protected] stream => object(Zend\Diactoros\PhpInputStream) {} [protected] uri => object(Zend\Diactoros\Uri) {} [protected] session => object(Cake\Http\Session) {} [protected] attributes => [[maximum depth reached]] [protected] emulatedAttributes => [ [maximum depth reached] ] [protected] uploadedFiles => [[maximum depth reached]] [protected] protocol => null [protected] requestTarget => null [private] deprecatedProperties => [ [maximum depth reached] ] }, 'type' => '->', 'args' => [ (int) 0 => 'catslug' ] ]deprecationWarning - CORE/src/Core/functions.php, line 311 Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421 App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73 Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51 Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98
Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]Code Context
trigger_error($message, E_USER_DEPRECATED);
}
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.' $stackFrame = (int) 1 $trace = [ (int) 0 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php', 'line' => (int) 2421, 'function' => 'deprecationWarning', 'args' => [ (int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.' ] ], (int) 1 => [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 74, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) {}, 'type' => '->', 'args' => [ (int) 0 => 'artileslug' ] ], (int) 2 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php', 'line' => (int) 610, 'function' => 'printArticle', 'class' => 'App\Controller\ArtileDetailController', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 3 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 120, 'function' => 'invokeAction', 'class' => 'Cake\Controller\Controller', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 4 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 94, 'function' => '_invoke', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(App\Controller\ArtileDetailController) {} ] ], (int) 5 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php', 'line' => (int) 235, 'function' => 'dispatch', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 6 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Http\BaseApplication', 'object' => object(App\Application) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 7 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php', 'line' => (int) 162, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 8 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\RoutingMiddleware', 'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 9 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php', 'line' => (int) 88, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 10 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\AssetMiddleware', 'object' => object(Cake\Routing\Middleware\AssetMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 11 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php', 'line' => (int) 96, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 12 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware', 'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 13 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 51, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 14 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php', 'line' => (int) 98, 'function' => 'run', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\MiddlewareQueue) {}, (int) 1 => object(Cake\Http\ServerRequest) {}, (int) 2 => object(Cake\Http\Response) {} ] ], (int) 15 => [ 'file' => '/home/brlfuser/public_html/webroot/index.php', 'line' => (int) 39, 'function' => 'run', 'class' => 'Cake\Http\Server', 'object' => object(Cake\Http\Server) {}, 'type' => '->', 'args' => [] ] ] $frame = [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 74, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) { trustProxy => false [protected] params => [ [maximum depth reached] ] [protected] data => [[maximum depth reached]] [protected] query => [[maximum depth reached]] [protected] cookies => [ [maximum depth reached] ] [protected] _environment => [ [maximum depth reached] ] [protected] url => 'latest-news-updates/northeast-hiv-tests-hit-by-reagent-hurdle-gs-mudur-21891/print' [protected] base => '' [protected] webroot => '/' [protected] here => '/latest-news-updates/northeast-hiv-tests-hit-by-reagent-hurdle-gs-mudur-21891/print' [protected] trustedProxies => [[maximum depth reached]] [protected] _input => null [protected] _detectors => [ [maximum depth reached] ] [protected] _detectorCache => [ [maximum depth reached] ] [protected] stream => object(Zend\Diactoros\PhpInputStream) {} [protected] uri => object(Zend\Diactoros\Uri) {} [protected] session => object(Cake\Http\Session) {} [protected] attributes => [[maximum depth reached]] [protected] emulatedAttributes => [ [maximum depth reached] ] [protected] uploadedFiles => [[maximum depth reached]] [protected] protocol => null [protected] requestTarget => null [private] deprecatedProperties => [ [maximum depth reached] ] }, 'type' => '->', 'args' => [ (int) 0 => 'artileslug' ] ]deprecationWarning - CORE/src/Core/functions.php, line 311 Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421 App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74 Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51 Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98
Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]Code Contextif (Configure::read('debug')) {
trigger_error($message, E_USER_WARNING);
} else {
$response = object(Cake\Http\Response) { 'status' => (int) 200, 'contentType' => 'text/html', 'headers' => [ 'Content-Type' => [ [maximum depth reached] ] ], 'file' => null, 'fileRange' => [], 'cookies' => object(Cake\Http\Cookie\CookieCollection) {}, 'cacheDirectives' => [], 'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <html xmlns="http://www.w3.org/1999/xhtml"> <head> <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ecc186433ae-trace').style.display = (document.getElementById('cakeErr67ecc186433ae-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67ecc186433ae-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ecc186433ae-code').style.display = (document.getElementById('cakeErr67ecc186433ae-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ecc186433ae-context').style.display = (document.getElementById('cakeErr67ecc186433ae-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67ecc186433ae-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">> </span></span></code> <span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/> </span></code></span> <code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/> </span></span></code></pre><pre id="cakeErr67ecc186433ae-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 21743, 'title' => 'Northeast HIV tests hit by reagent hurdle-GS Mudur', 'subheading' => '', 'description' => '<div align="justify"> -The Telegraph </div> <p align="justify"> <br /> <em>New Delhi: </em>Patients infected with the human immuno-deficiency virus (HIV) in the northeastern states have been unable to undergo a key test required to start anti-HIV drugs for several weeks because of delays in procurement by government agencies, patient interest groups said today. </p> <p align="justify"> The Indian Drug Users Forum said several government HIV-treatment centres across Manipur, Meghalaya, Nagaland and Tripura are facing a &quot;complete stock-out&quot; of biochemical reagents that measure levels of white blood cells called CD4 T-cells in HIV-infected persons. The CD4 levels are critical to make decisions to initiate therapy to prolong the lives of HIV patients. </p> <p align="justify"> Current guidelines recommend patients who have CD4 count less than 350 cells per mm should start taking the anti-HIV drugs. &quot;The stock-out keeps patients in the dark. Without CD4 counts, patients won't know when to start therapy,&quot; said Vikas Ahuja, president of the Network of Positive People. </p> <p align="justify"> The forum claimed that state AIDS control societies in the Northeast had written to the laboratory services division of the National AIDS Control Organisation (NACO). But none of the states have received any response despite several reminders, the forum said. </p> <p align="justify"> A senior NACO official told The Telegraph that procurement delays have led to the shortage of CD4 testing reagents but claimed the shortage has affected only a few HIV-treatment centres in the region. &quot;We're trying to streamline the procurement process. We've already got some deliveries and we expect all centres will have reagents in about seven to 10 days,&quot; the official said. </p> <p align="justify"> In a statement issued today, the network said while the Union health ministry had contracted the procurement of anti-HIV drugs and reagents for testing CD4 levels to a procurement agency, the ministry had not renewed the contract for nearly two years. It said this has led to &quot;serious delays&quot; in the procurement of CD4 testing kits for the HIV control programme. The NACO official declined to provide details of the delay in procurement but said it may have something to do with officials moving across government departments. </p> <p align="justify"> This poor management of the supply chain mechanism is holding up treatment for those who may urgently need to start the anti-HIV drug therapy, the forum based in Kohima said in a letter sent to NACO. Patients who have already initiated anti-HIV therapy also need to undergo CD4 counts every six months to determine the therapy is working. </p> <p align="justify"> &quot;It is shocking that doctors will not be able to initiate or monitor treatment of people living with HIV. This is unacceptable,&quot; Loon Gangte, a member of the Delhi Network of Positive People said in a statement this evening. </p> <p align="justify"> Among the 252 government centres across India that monitor CD4 levels of HIV patients, the northeastern states have 17 centres. But Ahuja said the shortage has also affected some centres in New Delhi. A NACO official said patients already on anti-HIV therapy are unlikely to be affected by the shortage of CD4 testing kits because they require a test only every six months. &quot;The acute shortage is only a few days to weeks old,&quot; he said. </p>', 'credit_writer' => 'The Telegraph, 11 July, 2013, http://www.telegraphindia.com/1130711/jsp/frontpage/story_17103992.jsp#.Ud5M7qzcjco', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'northeast-hiv-tests-hit-by-reagent-hurdle-gs-mudur-21891', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 21891, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ [maximum depth reached] ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 21743, 'metaTitle' => 'LATEST NEWS UPDATES | Northeast HIV tests hit by reagent hurdle-GS Mudur', 'metaKeywords' => 'HIV AIDS,Health,North East', 'metaDesc' => ' -The Telegraph New Delhi: Patients infected with the human immuno-deficiency virus (HIV) in the northeastern states have been unable to undergo a key test required to start anti-HIV drugs for several weeks because of delays in procurement by government agencies, patient...', 'disp' => '<div align="justify">-The Telegraph</div><p align="justify"><br /><em>New Delhi: </em>Patients infected with the human immuno-deficiency virus (HIV) in the northeastern states have been unable to undergo a key test required to start anti-HIV drugs for several weeks because of delays in procurement by government agencies, patient interest groups said today.</p><p align="justify">The Indian Drug Users Forum said several government HIV-treatment centres across Manipur, Meghalaya, Nagaland and Tripura are facing a &quot;complete stock-out&quot; of biochemical reagents that measure levels of white blood cells called CD4 T-cells in HIV-infected persons. The CD4 levels are critical to make decisions to initiate therapy to prolong the lives of HIV patients.</p><p align="justify">Current guidelines recommend patients who have CD4 count less than 350 cells per mm should start taking the anti-HIV drugs. &quot;The stock-out keeps patients in the dark. Without CD4 counts, patients won't know when to start therapy,&quot; said Vikas Ahuja, president of the Network of Positive People.</p><p align="justify">The forum claimed that state AIDS control societies in the Northeast had written to the laboratory services division of the National AIDS Control Organisation (NACO). But none of the states have received any response despite several reminders, the forum said.</p><p align="justify">A senior NACO official told The Telegraph that procurement delays have led to the shortage of CD4 testing reagents but claimed the shortage has affected only a few HIV-treatment centres in the region. &quot;We're trying to streamline the procurement process. We've already got some deliveries and we expect all centres will have reagents in about seven to 10 days,&quot; the official said.</p><p align="justify">In a statement issued today, the network said while the Union health ministry had contracted the procurement of anti-HIV drugs and reagents for testing CD4 levels to a procurement agency, the ministry had not renewed the contract for nearly two years. It said this has led to &quot;serious delays&quot; in the procurement of CD4 testing kits for the HIV control programme. The NACO official declined to provide details of the delay in procurement but said it may have something to do with officials moving across government departments.</p><p align="justify">This poor management of the supply chain mechanism is holding up treatment for those who may urgently need to start the anti-HIV drug therapy, the forum based in Kohima said in a letter sent to NACO. Patients who have already initiated anti-HIV therapy also need to undergo CD4 counts every six months to determine the therapy is working.</p><p align="justify">&quot;It is shocking that doctors will not be able to initiate or monitor treatment of people living with HIV. This is unacceptable,&quot; Loon Gangte, a member of the Delhi Network of Positive People said in a statement this evening.</p><p align="justify">Among the 252 government centres across India that monitor CD4 levels of HIV patients, the northeastern states have 17 centres. But Ahuja said the shortage has also affected some centres in New Delhi. A NACO official said patients already on anti-HIV therapy are unlikely to be affected by the shortage of CD4 testing kits because they require a test only every six months. &quot;The acute shortage is only a few days to weeks old,&quot; he said.</p>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 21743, 'title' => 'Northeast HIV tests hit by reagent hurdle-GS Mudur', 'subheading' => '', 'description' => '<div align="justify"> -The Telegraph </div> <p align="justify"> <br /> <em>New Delhi: </em>Patients infected with the human immuno-deficiency virus (HIV) in the northeastern states have been unable to undergo a key test required to start anti-HIV drugs for several weeks because of delays in procurement by government agencies, patient interest groups said today. </p> <p align="justify"> The Indian Drug Users Forum said several government HIV-treatment centres across Manipur, Meghalaya, Nagaland and Tripura are facing a &quot;complete stock-out&quot; of biochemical reagents that measure levels of white blood cells called CD4 T-cells in HIV-infected persons. The CD4 levels are critical to make decisions to initiate therapy to prolong the lives of HIV patients. </p> <p align="justify"> Current guidelines recommend patients who have CD4 count less than 350 cells per mm should start taking the anti-HIV drugs. &quot;The stock-out keeps patients in the dark. Without CD4 counts, patients won't know when to start therapy,&quot; said Vikas Ahuja, president of the Network of Positive People. </p> <p align="justify"> The forum claimed that state AIDS control societies in the Northeast had written to the laboratory services division of the National AIDS Control Organisation (NACO). But none of the states have received any response despite several reminders, the forum said. </p> <p align="justify"> A senior NACO official told The Telegraph that procurement delays have led to the shortage of CD4 testing reagents but claimed the shortage has affected only a few HIV-treatment centres in the region. &quot;We're trying to streamline the procurement process. We've already got some deliveries and we expect all centres will have reagents in about seven to 10 days,&quot; the official said. </p> <p align="justify"> In a statement issued today, the network said while the Union health ministry had contracted the procurement of anti-HIV drugs and reagents for testing CD4 levels to a procurement agency, the ministry had not renewed the contract for nearly two years. It said this has led to &quot;serious delays&quot; in the procurement of CD4 testing kits for the HIV control programme. The NACO official declined to provide details of the delay in procurement but said it may have something to do with officials moving across government departments. </p> <p align="justify"> This poor management of the supply chain mechanism is holding up treatment for those who may urgently need to start the anti-HIV drug therapy, the forum based in Kohima said in a letter sent to NACO. Patients who have already initiated anti-HIV therapy also need to undergo CD4 counts every six months to determine the therapy is working. </p> <p align="justify"> &quot;It is shocking that doctors will not be able to initiate or monitor treatment of people living with HIV. This is unacceptable,&quot; Loon Gangte, a member of the Delhi Network of Positive People said in a statement this evening. </p> <p align="justify"> Among the 252 government centres across India that monitor CD4 levels of HIV patients, the northeastern states have 17 centres. But Ahuja said the shortage has also affected some centres in New Delhi. A NACO official said patients already on anti-HIV therapy are unlikely to be affected by the shortage of CD4 testing kits because they require a test only every six months. &quot;The acute shortage is only a few days to weeks old,&quot; he said. </p>', 'credit_writer' => 'The Telegraph, 11 July, 2013, http://www.telegraphindia.com/1130711/jsp/frontpage/story_17103992.jsp#.Ud5M7qzcjco', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'northeast-hiv-tests-hit-by-reagent-hurdle-gs-mudur-21891', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 21891, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ (int) 0 => object(Cake\ORM\Entity) {}, (int) 1 => object(Cake\ORM\Entity) {}, (int) 2 => object(Cake\ORM\Entity) {} ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 21743 $metaTitle = 'LATEST NEWS UPDATES | Northeast HIV tests hit by reagent hurdle-GS Mudur' $metaKeywords = 'HIV AIDS,Health,North East' $metaDesc = ' -The Telegraph New Delhi: Patients infected with the human immuno-deficiency virus (HIV) in the northeastern states have been unable to undergo a key test required to start anti-HIV drugs for several weeks because of delays in procurement by government agencies, patient...' $disp = '<div align="justify">-The Telegraph</div><p align="justify"><br /><em>New Delhi: </em>Patients infected with the human immuno-deficiency virus (HIV) in the northeastern states have been unable to undergo a key test required to start anti-HIV drugs for several weeks because of delays in procurement by government agencies, patient interest groups said today.</p><p align="justify">The Indian Drug Users Forum said several government HIV-treatment centres across Manipur, Meghalaya, Nagaland and Tripura are facing a &quot;complete stock-out&quot; of biochemical reagents that measure levels of white blood cells called CD4 T-cells in HIV-infected persons. The CD4 levels are critical to make decisions to initiate therapy to prolong the lives of HIV patients.</p><p align="justify">Current guidelines recommend patients who have CD4 count less than 350 cells per mm should start taking the anti-HIV drugs. &quot;The stock-out keeps patients in the dark. Without CD4 counts, patients won't know when to start therapy,&quot; said Vikas Ahuja, president of the Network of Positive People.</p><p align="justify">The forum claimed that state AIDS control societies in the Northeast had written to the laboratory services division of the National AIDS Control Organisation (NACO). But none of the states have received any response despite several reminders, the forum said.</p><p align="justify">A senior NACO official told The Telegraph that procurement delays have led to the shortage of CD4 testing reagents but claimed the shortage has affected only a few HIV-treatment centres in the region. &quot;We're trying to streamline the procurement process. We've already got some deliveries and we expect all centres will have reagents in about seven to 10 days,&quot; the official said.</p><p align="justify">In a statement issued today, the network said while the Union health ministry had contracted the procurement of anti-HIV drugs and reagents for testing CD4 levels to a procurement agency, the ministry had not renewed the contract for nearly two years. It said this has led to &quot;serious delays&quot; in the procurement of CD4 testing kits for the HIV control programme. The NACO official declined to provide details of the delay in procurement but said it may have something to do with officials moving across government departments.</p><p align="justify">This poor management of the supply chain mechanism is holding up treatment for those who may urgently need to start the anti-HIV drug therapy, the forum based in Kohima said in a letter sent to NACO. Patients who have already initiated anti-HIV therapy also need to undergo CD4 counts every six months to determine the therapy is working.</p><p align="justify">&quot;It is shocking that doctors will not be able to initiate or monitor treatment of people living with HIV. This is unacceptable,&quot; Loon Gangte, a member of the Delhi Network of Positive People said in a statement this evening.</p><p align="justify">Among the 252 government centres across India that monitor CD4 levels of HIV patients, the northeastern states have 17 centres. But Ahuja said the shortage has also affected some centres in New Delhi. A NACO official said patients already on anti-HIV therapy are unlikely to be affected by the shortage of CD4 testing kits because they require a test only every six months. &quot;The acute shortage is only a few days to weeks old,&quot; he said.</p>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/northeast-hiv-tests-hit-by-reagent-hurdle-gs-mudur-21891.html"/> <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css" media="all"/> <title>LATEST NEWS UPDATES | Northeast HIV tests hit by reagent hurdle-GS Mudur | Im4change.org</title> <meta name="description" content=" -The Telegraph New Delhi: Patients infected with the human immuno-deficiency virus (HIV) in the northeastern states have been unable to undergo a key test required to start anti-HIV drugs for several weeks because of delays in procurement by government agencies, patient..."/> <script src="https://im4change.in/js/jquery-1.10.2.js"></script> <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script> <script language="javascript" type="text/javascript"> $(document).ready(function () { var img = $("img")[0]; // Get my img elem var pic_real_width, pic_real_height; $("<img/>") // Make in memory copy of image to avoid css issues .attr("src", $(img).attr("src")) .load(function () { pic_real_width = this.width; // Note: $(this).width() will not pic_real_height = this.height; // work for in memory images. }); }); </script> <style type="text/css"> @media screen { div.divFooter { display: block; } } @media print { .printbutton { display: none !important; } } </style> </head> <body> <table cellpadding="0" cellspacing="0" border="0" width="98%" align="center"> <tr> <td class="top_bg"> <div class="divFooter"> <img src="https://im4change.in/images/logo1.jpg" height="59" border="0" alt="Resource centre on India's rural distress" style="padding-top:14px;"/> </div> </td> </tr> <tr> <td id="topspace"> </td> </tr> <tr id="topspace"> <td> </td> </tr> <tr> <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> <tr> <td width="100%"> <h1 class="news_headlines" style="font-style:normal"> <strong>Northeast HIV tests hit by reagent hurdle-GS Mudur</strong></h1> </td> </tr> <tr> <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3"> <div align="justify">-The Telegraph</div><p align="justify"><br /><em>New Delhi: </em>Patients infected with the human immuno-deficiency virus (HIV) in the northeastern states have been unable to undergo a key test required to start anti-HIV drugs for several weeks because of delays in procurement by government agencies, patient interest groups said today.</p><p align="justify">The Indian Drug Users Forum said several government HIV-treatment centres across Manipur, Meghalaya, Nagaland and Tripura are facing a "complete stock-out" of biochemical reagents that measure levels of white blood cells called CD4 T-cells in HIV-infected persons. The CD4 levels are critical to make decisions to initiate therapy to prolong the lives of HIV patients.</p><p align="justify">Current guidelines recommend patients who have CD4 count less than 350 cells per mm should start taking the anti-HIV drugs. "The stock-out keeps patients in the dark. Without CD4 counts, patients won't know when to start therapy," said Vikas Ahuja, president of the Network of Positive People.</p><p align="justify">The forum claimed that state AIDS control societies in the Northeast had written to the laboratory services division of the National AIDS Control Organisation (NACO). But none of the states have received any response despite several reminders, the forum said.</p><p align="justify">A senior NACO official told The Telegraph that procurement delays have led to the shortage of CD4 testing reagents but claimed the shortage has affected only a few HIV-treatment centres in the region. "We're trying to streamline the procurement process. We've already got some deliveries and we expect all centres will have reagents in about seven to 10 days," the official said.</p><p align="justify">In a statement issued today, the network said while the Union health ministry had contracted the procurement of anti-HIV drugs and reagents for testing CD4 levels to a procurement agency, the ministry had not renewed the contract for nearly two years. It said this has led to "serious delays" in the procurement of CD4 testing kits for the HIV control programme. The NACO official declined to provide details of the delay in procurement but said it may have something to do with officials moving across government departments.</p><p align="justify">This poor management of the supply chain mechanism is holding up treatment for those who may urgently need to start the anti-HIV drug therapy, the forum based in Kohima said in a letter sent to NACO. Patients who have already initiated anti-HIV therapy also need to undergo CD4 counts every six months to determine the therapy is working.</p><p align="justify">"It is shocking that doctors will not be able to initiate or monitor treatment of people living with HIV. This is unacceptable," Loon Gangte, a member of the Delhi Network of Positive People said in a statement this evening.</p><p align="justify">Among the 252 government centres across India that monitor CD4 levels of HIV patients, the northeastern states have 17 centres. But Ahuja said the shortage has also affected some centres in New Delhi. A NACO official said patients already on anti-HIV therapy are unlikely to be affected by the shortage of CD4 testing kits because they require a test only every six months. "The acute shortage is only a few days to weeks old," he said.</p> </font> </td> </tr> <tr> <td> </td> </tr> <tr> <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> </table></body> </html>' } $maxBufferLength = (int) 8192 $file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php' $line = (int) 853 $message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48 Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141 [main] - ROOT/webroot/index.php, line 39
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]Code Context$response->getStatusCode(),
($reasonPhrase ? ' ' . $reasonPhrase : '')
));
$response = object(Cake\Http\Response) { 'status' => (int) 200, 'contentType' => 'text/html', 'headers' => [ 'Content-Type' => [ [maximum depth reached] ] ], 'file' => null, 'fileRange' => [], 'cookies' => object(Cake\Http\Cookie\CookieCollection) {}, 'cacheDirectives' => [], 'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <html xmlns="http://www.w3.org/1999/xhtml"> <head> <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ecc186433ae-trace').style.display = (document.getElementById('cakeErr67ecc186433ae-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67ecc186433ae-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ecc186433ae-code').style.display = (document.getElementById('cakeErr67ecc186433ae-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ecc186433ae-context').style.display = (document.getElementById('cakeErr67ecc186433ae-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67ecc186433ae-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">> </span></span></code> <span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/> </span></code></span> <code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/> </span></span></code></pre><pre id="cakeErr67ecc186433ae-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 21743, 'title' => 'Northeast HIV tests hit by reagent hurdle-GS Mudur', 'subheading' => '', 'description' => '<div align="justify"> -The Telegraph </div> <p align="justify"> <br /> <em>New Delhi: </em>Patients infected with the human immuno-deficiency virus (HIV) in the northeastern states have been unable to undergo a key test required to start anti-HIV drugs for several weeks because of delays in procurement by government agencies, patient interest groups said today. </p> <p align="justify"> The Indian Drug Users Forum said several government HIV-treatment centres across Manipur, Meghalaya, Nagaland and Tripura are facing a &quot;complete stock-out&quot; of biochemical reagents that measure levels of white blood cells called CD4 T-cells in HIV-infected persons. The CD4 levels are critical to make decisions to initiate therapy to prolong the lives of HIV patients. </p> <p align="justify"> Current guidelines recommend patients who have CD4 count less than 350 cells per mm should start taking the anti-HIV drugs. &quot;The stock-out keeps patients in the dark. Without CD4 counts, patients won't know when to start therapy,&quot; said Vikas Ahuja, president of the Network of Positive People. </p> <p align="justify"> The forum claimed that state AIDS control societies in the Northeast had written to the laboratory services division of the National AIDS Control Organisation (NACO). But none of the states have received any response despite several reminders, the forum said. </p> <p align="justify"> A senior NACO official told The Telegraph that procurement delays have led to the shortage of CD4 testing reagents but claimed the shortage has affected only a few HIV-treatment centres in the region. &quot;We're trying to streamline the procurement process. We've already got some deliveries and we expect all centres will have reagents in about seven to 10 days,&quot; the official said. </p> <p align="justify"> In a statement issued today, the network said while the Union health ministry had contracted the procurement of anti-HIV drugs and reagents for testing CD4 levels to a procurement agency, the ministry had not renewed the contract for nearly two years. It said this has led to &quot;serious delays&quot; in the procurement of CD4 testing kits for the HIV control programme. The NACO official declined to provide details of the delay in procurement but said it may have something to do with officials moving across government departments. </p> <p align="justify"> This poor management of the supply chain mechanism is holding up treatment for those who may urgently need to start the anti-HIV drug therapy, the forum based in Kohima said in a letter sent to NACO. Patients who have already initiated anti-HIV therapy also need to undergo CD4 counts every six months to determine the therapy is working. </p> <p align="justify"> &quot;It is shocking that doctors will not be able to initiate or monitor treatment of people living with HIV. This is unacceptable,&quot; Loon Gangte, a member of the Delhi Network of Positive People said in a statement this evening. </p> <p align="justify"> Among the 252 government centres across India that monitor CD4 levels of HIV patients, the northeastern states have 17 centres. But Ahuja said the shortage has also affected some centres in New Delhi. A NACO official said patients already on anti-HIV therapy are unlikely to be affected by the shortage of CD4 testing kits because they require a test only every six months. &quot;The acute shortage is only a few days to weeks old,&quot; he said. </p>', 'credit_writer' => 'The Telegraph, 11 July, 2013, http://www.telegraphindia.com/1130711/jsp/frontpage/story_17103992.jsp#.Ud5M7qzcjco', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'northeast-hiv-tests-hit-by-reagent-hurdle-gs-mudur-21891', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 21891, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ [maximum depth reached] ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 21743, 'metaTitle' => 'LATEST NEWS UPDATES | Northeast HIV tests hit by reagent hurdle-GS Mudur', 'metaKeywords' => 'HIV AIDS,Health,North East', 'metaDesc' => ' -The Telegraph New Delhi: Patients infected with the human immuno-deficiency virus (HIV) in the northeastern states have been unable to undergo a key test required to start anti-HIV drugs for several weeks because of delays in procurement by government agencies, patient...', 'disp' => '<div align="justify">-The Telegraph</div><p align="justify"><br /><em>New Delhi: </em>Patients infected with the human immuno-deficiency virus (HIV) in the northeastern states have been unable to undergo a key test required to start anti-HIV drugs for several weeks because of delays in procurement by government agencies, patient interest groups said today.</p><p align="justify">The Indian Drug Users Forum said several government HIV-treatment centres across Manipur, Meghalaya, Nagaland and Tripura are facing a &quot;complete stock-out&quot; of biochemical reagents that measure levels of white blood cells called CD4 T-cells in HIV-infected persons. The CD4 levels are critical to make decisions to initiate therapy to prolong the lives of HIV patients.</p><p align="justify">Current guidelines recommend patients who have CD4 count less than 350 cells per mm should start taking the anti-HIV drugs. &quot;The stock-out keeps patients in the dark. Without CD4 counts, patients won't know when to start therapy,&quot; said Vikas Ahuja, president of the Network of Positive People.</p><p align="justify">The forum claimed that state AIDS control societies in the Northeast had written to the laboratory services division of the National AIDS Control Organisation (NACO). But none of the states have received any response despite several reminders, the forum said.</p><p align="justify">A senior NACO official told The Telegraph that procurement delays have led to the shortage of CD4 testing reagents but claimed the shortage has affected only a few HIV-treatment centres in the region. &quot;We're trying to streamline the procurement process. We've already got some deliveries and we expect all centres will have reagents in about seven to 10 days,&quot; the official said.</p><p align="justify">In a statement issued today, the network said while the Union health ministry had contracted the procurement of anti-HIV drugs and reagents for testing CD4 levels to a procurement agency, the ministry had not renewed the contract for nearly two years. It said this has led to &quot;serious delays&quot; in the procurement of CD4 testing kits for the HIV control programme. The NACO official declined to provide details of the delay in procurement but said it may have something to do with officials moving across government departments.</p><p align="justify">This poor management of the supply chain mechanism is holding up treatment for those who may urgently need to start the anti-HIV drug therapy, the forum based in Kohima said in a letter sent to NACO. Patients who have already initiated anti-HIV therapy also need to undergo CD4 counts every six months to determine the therapy is working.</p><p align="justify">&quot;It is shocking that doctors will not be able to initiate or monitor treatment of people living with HIV. This is unacceptable,&quot; Loon Gangte, a member of the Delhi Network of Positive People said in a statement this evening.</p><p align="justify">Among the 252 government centres across India that monitor CD4 levels of HIV patients, the northeastern states have 17 centres. But Ahuja said the shortage has also affected some centres in New Delhi. A NACO official said patients already on anti-HIV therapy are unlikely to be affected by the shortage of CD4 testing kits because they require a test only every six months. &quot;The acute shortage is only a few days to weeks old,&quot; he said.</p>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 21743, 'title' => 'Northeast HIV tests hit by reagent hurdle-GS Mudur', 'subheading' => '', 'description' => '<div align="justify"> -The Telegraph </div> <p align="justify"> <br /> <em>New Delhi: </em>Patients infected with the human immuno-deficiency virus (HIV) in the northeastern states have been unable to undergo a key test required to start anti-HIV drugs for several weeks because of delays in procurement by government agencies, patient interest groups said today. </p> <p align="justify"> The Indian Drug Users Forum said several government HIV-treatment centres across Manipur, Meghalaya, Nagaland and Tripura are facing a &quot;complete stock-out&quot; of biochemical reagents that measure levels of white blood cells called CD4 T-cells in HIV-infected persons. The CD4 levels are critical to make decisions to initiate therapy to prolong the lives of HIV patients. </p> <p align="justify"> Current guidelines recommend patients who have CD4 count less than 350 cells per mm should start taking the anti-HIV drugs. &quot;The stock-out keeps patients in the dark. Without CD4 counts, patients won't know when to start therapy,&quot; said Vikas Ahuja, president of the Network of Positive People. </p> <p align="justify"> The forum claimed that state AIDS control societies in the Northeast had written to the laboratory services division of the National AIDS Control Organisation (NACO). But none of the states have received any response despite several reminders, the forum said. </p> <p align="justify"> A senior NACO official told The Telegraph that procurement delays have led to the shortage of CD4 testing reagents but claimed the shortage has affected only a few HIV-treatment centres in the region. &quot;We're trying to streamline the procurement process. We've already got some deliveries and we expect all centres will have reagents in about seven to 10 days,&quot; the official said. </p> <p align="justify"> In a statement issued today, the network said while the Union health ministry had contracted the procurement of anti-HIV drugs and reagents for testing CD4 levels to a procurement agency, the ministry had not renewed the contract for nearly two years. It said this has led to &quot;serious delays&quot; in the procurement of CD4 testing kits for the HIV control programme. The NACO official declined to provide details of the delay in procurement but said it may have something to do with officials moving across government departments. </p> <p align="justify"> This poor management of the supply chain mechanism is holding up treatment for those who may urgently need to start the anti-HIV drug therapy, the forum based in Kohima said in a letter sent to NACO. Patients who have already initiated anti-HIV therapy also need to undergo CD4 counts every six months to determine the therapy is working. </p> <p align="justify"> &quot;It is shocking that doctors will not be able to initiate or monitor treatment of people living with HIV. This is unacceptable,&quot; Loon Gangte, a member of the Delhi Network of Positive People said in a statement this evening. </p> <p align="justify"> Among the 252 government centres across India that monitor CD4 levels of HIV patients, the northeastern states have 17 centres. But Ahuja said the shortage has also affected some centres in New Delhi. A NACO official said patients already on anti-HIV therapy are unlikely to be affected by the shortage of CD4 testing kits because they require a test only every six months. &quot;The acute shortage is only a few days to weeks old,&quot; he said. </p>', 'credit_writer' => 'The Telegraph, 11 July, 2013, http://www.telegraphindia.com/1130711/jsp/frontpage/story_17103992.jsp#.Ud5M7qzcjco', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'northeast-hiv-tests-hit-by-reagent-hurdle-gs-mudur-21891', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 21891, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ (int) 0 => object(Cake\ORM\Entity) {}, (int) 1 => object(Cake\ORM\Entity) {}, (int) 2 => object(Cake\ORM\Entity) {} ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 21743 $metaTitle = 'LATEST NEWS UPDATES | Northeast HIV tests hit by reagent hurdle-GS Mudur' $metaKeywords = 'HIV AIDS,Health,North East' $metaDesc = ' -The Telegraph New Delhi: Patients infected with the human immuno-deficiency virus (HIV) in the northeastern states have been unable to undergo a key test required to start anti-HIV drugs for several weeks because of delays in procurement by government agencies, patient...' $disp = '<div align="justify">-The Telegraph</div><p align="justify"><br /><em>New Delhi: </em>Patients infected with the human immuno-deficiency virus (HIV) in the northeastern states have been unable to undergo a key test required to start anti-HIV drugs for several weeks because of delays in procurement by government agencies, patient interest groups said today.</p><p align="justify">The Indian Drug Users Forum said several government HIV-treatment centres across Manipur, Meghalaya, Nagaland and Tripura are facing a &quot;complete stock-out&quot; of biochemical reagents that measure levels of white blood cells called CD4 T-cells in HIV-infected persons. The CD4 levels are critical to make decisions to initiate therapy to prolong the lives of HIV patients.</p><p align="justify">Current guidelines recommend patients who have CD4 count less than 350 cells per mm should start taking the anti-HIV drugs. &quot;The stock-out keeps patients in the dark. Without CD4 counts, patients won't know when to start therapy,&quot; said Vikas Ahuja, president of the Network of Positive People.</p><p align="justify">The forum claimed that state AIDS control societies in the Northeast had written to the laboratory services division of the National AIDS Control Organisation (NACO). But none of the states have received any response despite several reminders, the forum said.</p><p align="justify">A senior NACO official told The Telegraph that procurement delays have led to the shortage of CD4 testing reagents but claimed the shortage has affected only a few HIV-treatment centres in the region. &quot;We're trying to streamline the procurement process. We've already got some deliveries and we expect all centres will have reagents in about seven to 10 days,&quot; the official said.</p><p align="justify">In a statement issued today, the network said while the Union health ministry had contracted the procurement of anti-HIV drugs and reagents for testing CD4 levels to a procurement agency, the ministry had not renewed the contract for nearly two years. It said this has led to &quot;serious delays&quot; in the procurement of CD4 testing kits for the HIV control programme. The NACO official declined to provide details of the delay in procurement but said it may have something to do with officials moving across government departments.</p><p align="justify">This poor management of the supply chain mechanism is holding up treatment for those who may urgently need to start the anti-HIV drug therapy, the forum based in Kohima said in a letter sent to NACO. Patients who have already initiated anti-HIV therapy also need to undergo CD4 counts every six months to determine the therapy is working.</p><p align="justify">&quot;It is shocking that doctors will not be able to initiate or monitor treatment of people living with HIV. This is unacceptable,&quot; Loon Gangte, a member of the Delhi Network of Positive People said in a statement this evening.</p><p align="justify">Among the 252 government centres across India that monitor CD4 levels of HIV patients, the northeastern states have 17 centres. But Ahuja said the shortage has also affected some centres in New Delhi. A NACO official said patients already on anti-HIV therapy are unlikely to be affected by the shortage of CD4 testing kits because they require a test only every six months. &quot;The acute shortage is only a few days to weeks old,&quot; he said.</p>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/northeast-hiv-tests-hit-by-reagent-hurdle-gs-mudur-21891.html"/> <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css" media="all"/> <title>LATEST NEWS UPDATES | Northeast HIV tests hit by reagent hurdle-GS Mudur | Im4change.org</title> <meta name="description" content=" -The Telegraph New Delhi: Patients infected with the human immuno-deficiency virus (HIV) in the northeastern states have been unable to undergo a key test required to start anti-HIV drugs for several weeks because of delays in procurement by government agencies, patient..."/> <script src="https://im4change.in/js/jquery-1.10.2.js"></script> <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script> <script language="javascript" type="text/javascript"> $(document).ready(function () { var img = $("img")[0]; // Get my img elem var pic_real_width, pic_real_height; $("<img/>") // Make in memory copy of image to avoid css issues .attr("src", $(img).attr("src")) .load(function () { pic_real_width = this.width; // Note: $(this).width() will not pic_real_height = this.height; // work for in memory images. }); }); </script> <style type="text/css"> @media screen { div.divFooter { display: block; } } @media print { .printbutton { display: none !important; } } </style> </head> <body> <table cellpadding="0" cellspacing="0" border="0" width="98%" align="center"> <tr> <td class="top_bg"> <div class="divFooter"> <img src="https://im4change.in/images/logo1.jpg" height="59" border="0" alt="Resource centre on India's rural distress" style="padding-top:14px;"/> </div> </td> </tr> <tr> <td id="topspace"> </td> </tr> <tr id="topspace"> <td> </td> </tr> <tr> <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> <tr> <td width="100%"> <h1 class="news_headlines" style="font-style:normal"> <strong>Northeast HIV tests hit by reagent hurdle-GS Mudur</strong></h1> </td> </tr> <tr> <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3"> <div align="justify">-The Telegraph</div><p align="justify"><br /><em>New Delhi: </em>Patients infected with the human immuno-deficiency virus (HIV) in the northeastern states have been unable to undergo a key test required to start anti-HIV drugs for several weeks because of delays in procurement by government agencies, patient interest groups said today.</p><p align="justify">The Indian Drug Users Forum said several government HIV-treatment centres across Manipur, Meghalaya, Nagaland and Tripura are facing a "complete stock-out" of biochemical reagents that measure levels of white blood cells called CD4 T-cells in HIV-infected persons. The CD4 levels are critical to make decisions to initiate therapy to prolong the lives of HIV patients.</p><p align="justify">Current guidelines recommend patients who have CD4 count less than 350 cells per mm should start taking the anti-HIV drugs. "The stock-out keeps patients in the dark. Without CD4 counts, patients won't know when to start therapy," said Vikas Ahuja, president of the Network of Positive People.</p><p align="justify">The forum claimed that state AIDS control societies in the Northeast had written to the laboratory services division of the National AIDS Control Organisation (NACO). But none of the states have received any response despite several reminders, the forum said.</p><p align="justify">A senior NACO official told The Telegraph that procurement delays have led to the shortage of CD4 testing reagents but claimed the shortage has affected only a few HIV-treatment centres in the region. "We're trying to streamline the procurement process. We've already got some deliveries and we expect all centres will have reagents in about seven to 10 days," the official said.</p><p align="justify">In a statement issued today, the network said while the Union health ministry had contracted the procurement of anti-HIV drugs and reagents for testing CD4 levels to a procurement agency, the ministry had not renewed the contract for nearly two years. It said this has led to "serious delays" in the procurement of CD4 testing kits for the HIV control programme. The NACO official declined to provide details of the delay in procurement but said it may have something to do with officials moving across government departments.</p><p align="justify">This poor management of the supply chain mechanism is holding up treatment for those who may urgently need to start the anti-HIV drug therapy, the forum based in Kohima said in a letter sent to NACO. Patients who have already initiated anti-HIV therapy also need to undergo CD4 counts every six months to determine the therapy is working.</p><p align="justify">"It is shocking that doctors will not be able to initiate or monitor treatment of people living with HIV. This is unacceptable," Loon Gangte, a member of the Delhi Network of Positive People said in a statement this evening.</p><p align="justify">Among the 252 government centres across India that monitor CD4 levels of HIV patients, the northeastern states have 17 centres. But Ahuja said the shortage has also affected some centres in New Delhi. A NACO official said patients already on anti-HIV therapy are unlikely to be affected by the shortage of CD4 testing kits because they require a test only every six months. "The acute shortage is only a few days to weeks old," he said.</p> </font> </td> </tr> <tr> <td> </td> </tr> <tr> <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> </table></body> </html>' } $reasonPhrase = 'OK'header - [internal], line ?? Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148 Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54 Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141 [main] - ROOT/webroot/index.php, line 39
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]Notice (8): Undefined variable: urlPrefix [APP/Template/Layout/printlayout.ctp, line 8]Code Context$value
), $first);
$first = false;
$response = object(Cake\Http\Response) { 'status' => (int) 200, 'contentType' => 'text/html', 'headers' => [ 'Content-Type' => [ [maximum depth reached] ] ], 'file' => null, 'fileRange' => [], 'cookies' => object(Cake\Http\Cookie\CookieCollection) {}, 'cacheDirectives' => [], 'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <html xmlns="http://www.w3.org/1999/xhtml"> <head> <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ecc186433ae-trace').style.display = (document.getElementById('cakeErr67ecc186433ae-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67ecc186433ae-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ecc186433ae-code').style.display = (document.getElementById('cakeErr67ecc186433ae-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ecc186433ae-context').style.display = (document.getElementById('cakeErr67ecc186433ae-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67ecc186433ae-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">> </span></span></code> <span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/> </span></code></span> <code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/> </span></span></code></pre><pre id="cakeErr67ecc186433ae-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 21743, 'title' => 'Northeast HIV tests hit by reagent hurdle-GS Mudur', 'subheading' => '', 'description' => '<div align="justify"> -The Telegraph </div> <p align="justify"> <br /> <em>New Delhi: </em>Patients infected with the human immuno-deficiency virus (HIV) in the northeastern states have been unable to undergo a key test required to start anti-HIV drugs for several weeks because of delays in procurement by government agencies, patient interest groups said today. </p> <p align="justify"> The Indian Drug Users Forum said several government HIV-treatment centres across Manipur, Meghalaya, Nagaland and Tripura are facing a &quot;complete stock-out&quot; of biochemical reagents that measure levels of white blood cells called CD4 T-cells in HIV-infected persons. The CD4 levels are critical to make decisions to initiate therapy to prolong the lives of HIV patients. </p> <p align="justify"> Current guidelines recommend patients who have CD4 count less than 350 cells per mm should start taking the anti-HIV drugs. &quot;The stock-out keeps patients in the dark. Without CD4 counts, patients won't know when to start therapy,&quot; said Vikas Ahuja, president of the Network of Positive People. </p> <p align="justify"> The forum claimed that state AIDS control societies in the Northeast had written to the laboratory services division of the National AIDS Control Organisation (NACO). But none of the states have received any response despite several reminders, the forum said. </p> <p align="justify"> A senior NACO official told The Telegraph that procurement delays have led to the shortage of CD4 testing reagents but claimed the shortage has affected only a few HIV-treatment centres in the region. &quot;We're trying to streamline the procurement process. We've already got some deliveries and we expect all centres will have reagents in about seven to 10 days,&quot; the official said. </p> <p align="justify"> In a statement issued today, the network said while the Union health ministry had contracted the procurement of anti-HIV drugs and reagents for testing CD4 levels to a procurement agency, the ministry had not renewed the contract for nearly two years. It said this has led to &quot;serious delays&quot; in the procurement of CD4 testing kits for the HIV control programme. The NACO official declined to provide details of the delay in procurement but said it may have something to do with officials moving across government departments. </p> <p align="justify"> This poor management of the supply chain mechanism is holding up treatment for those who may urgently need to start the anti-HIV drug therapy, the forum based in Kohima said in a letter sent to NACO. Patients who have already initiated anti-HIV therapy also need to undergo CD4 counts every six months to determine the therapy is working. </p> <p align="justify"> &quot;It is shocking that doctors will not be able to initiate or monitor treatment of people living with HIV. This is unacceptable,&quot; Loon Gangte, a member of the Delhi Network of Positive People said in a statement this evening. </p> <p align="justify"> Among the 252 government centres across India that monitor CD4 levels of HIV patients, the northeastern states have 17 centres. But Ahuja said the shortage has also affected some centres in New Delhi. A NACO official said patients already on anti-HIV therapy are unlikely to be affected by the shortage of CD4 testing kits because they require a test only every six months. &quot;The acute shortage is only a few days to weeks old,&quot; he said. </p>', 'credit_writer' => 'The Telegraph, 11 July, 2013, http://www.telegraphindia.com/1130711/jsp/frontpage/story_17103992.jsp#.Ud5M7qzcjco', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'northeast-hiv-tests-hit-by-reagent-hurdle-gs-mudur-21891', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 21891, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ [maximum depth reached] ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 21743, 'metaTitle' => 'LATEST NEWS UPDATES | Northeast HIV tests hit by reagent hurdle-GS Mudur', 'metaKeywords' => 'HIV AIDS,Health,North East', 'metaDesc' => ' -The Telegraph New Delhi: Patients infected with the human immuno-deficiency virus (HIV) in the northeastern states have been unable to undergo a key test required to start anti-HIV drugs for several weeks because of delays in procurement by government agencies, patient...', 'disp' => '<div align="justify">-The Telegraph</div><p align="justify"><br /><em>New Delhi: </em>Patients infected with the human immuno-deficiency virus (HIV) in the northeastern states have been unable to undergo a key test required to start anti-HIV drugs for several weeks because of delays in procurement by government agencies, patient interest groups said today.</p><p align="justify">The Indian Drug Users Forum said several government HIV-treatment centres across Manipur, Meghalaya, Nagaland and Tripura are facing a &quot;complete stock-out&quot; of biochemical reagents that measure levels of white blood cells called CD4 T-cells in HIV-infected persons. The CD4 levels are critical to make decisions to initiate therapy to prolong the lives of HIV patients.</p><p align="justify">Current guidelines recommend patients who have CD4 count less than 350 cells per mm should start taking the anti-HIV drugs. &quot;The stock-out keeps patients in the dark. Without CD4 counts, patients won't know when to start therapy,&quot; said Vikas Ahuja, president of the Network of Positive People.</p><p align="justify">The forum claimed that state AIDS control societies in the Northeast had written to the laboratory services division of the National AIDS Control Organisation (NACO). But none of the states have received any response despite several reminders, the forum said.</p><p align="justify">A senior NACO official told The Telegraph that procurement delays have led to the shortage of CD4 testing reagents but claimed the shortage has affected only a few HIV-treatment centres in the region. &quot;We're trying to streamline the procurement process. We've already got some deliveries and we expect all centres will have reagents in about seven to 10 days,&quot; the official said.</p><p align="justify">In a statement issued today, the network said while the Union health ministry had contracted the procurement of anti-HIV drugs and reagents for testing CD4 levels to a procurement agency, the ministry had not renewed the contract for nearly two years. It said this has led to &quot;serious delays&quot; in the procurement of CD4 testing kits for the HIV control programme. The NACO official declined to provide details of the delay in procurement but said it may have something to do with officials moving across government departments.</p><p align="justify">This poor management of the supply chain mechanism is holding up treatment for those who may urgently need to start the anti-HIV drug therapy, the forum based in Kohima said in a letter sent to NACO. Patients who have already initiated anti-HIV therapy also need to undergo CD4 counts every six months to determine the therapy is working.</p><p align="justify">&quot;It is shocking that doctors will not be able to initiate or monitor treatment of people living with HIV. This is unacceptable,&quot; Loon Gangte, a member of the Delhi Network of Positive People said in a statement this evening.</p><p align="justify">Among the 252 government centres across India that monitor CD4 levels of HIV patients, the northeastern states have 17 centres. But Ahuja said the shortage has also affected some centres in New Delhi. A NACO official said patients already on anti-HIV therapy are unlikely to be affected by the shortage of CD4 testing kits because they require a test only every six months. &quot;The acute shortage is only a few days to weeks old,&quot; he said.</p>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 21743, 'title' => 'Northeast HIV tests hit by reagent hurdle-GS Mudur', 'subheading' => '', 'description' => '<div align="justify"> -The Telegraph </div> <p align="justify"> <br /> <em>New Delhi: </em>Patients infected with the human immuno-deficiency virus (HIV) in the northeastern states have been unable to undergo a key test required to start anti-HIV drugs for several weeks because of delays in procurement by government agencies, patient interest groups said today. </p> <p align="justify"> The Indian Drug Users Forum said several government HIV-treatment centres across Manipur, Meghalaya, Nagaland and Tripura are facing a &quot;complete stock-out&quot; of biochemical reagents that measure levels of white blood cells called CD4 T-cells in HIV-infected persons. The CD4 levels are critical to make decisions to initiate therapy to prolong the lives of HIV patients. </p> <p align="justify"> Current guidelines recommend patients who have CD4 count less than 350 cells per mm should start taking the anti-HIV drugs. &quot;The stock-out keeps patients in the dark. Without CD4 counts, patients won't know when to start therapy,&quot; said Vikas Ahuja, president of the Network of Positive People. </p> <p align="justify"> The forum claimed that state AIDS control societies in the Northeast had written to the laboratory services division of the National AIDS Control Organisation (NACO). But none of the states have received any response despite several reminders, the forum said. </p> <p align="justify"> A senior NACO official told The Telegraph that procurement delays have led to the shortage of CD4 testing reagents but claimed the shortage has affected only a few HIV-treatment centres in the region. &quot;We're trying to streamline the procurement process. We've already got some deliveries and we expect all centres will have reagents in about seven to 10 days,&quot; the official said. </p> <p align="justify"> In a statement issued today, the network said while the Union health ministry had contracted the procurement of anti-HIV drugs and reagents for testing CD4 levels to a procurement agency, the ministry had not renewed the contract for nearly two years. It said this has led to &quot;serious delays&quot; in the procurement of CD4 testing kits for the HIV control programme. The NACO official declined to provide details of the delay in procurement but said it may have something to do with officials moving across government departments. </p> <p align="justify"> This poor management of the supply chain mechanism is holding up treatment for those who may urgently need to start the anti-HIV drug therapy, the forum based in Kohima said in a letter sent to NACO. Patients who have already initiated anti-HIV therapy also need to undergo CD4 counts every six months to determine the therapy is working. </p> <p align="justify"> &quot;It is shocking that doctors will not be able to initiate or monitor treatment of people living with HIV. This is unacceptable,&quot; Loon Gangte, a member of the Delhi Network of Positive People said in a statement this evening. </p> <p align="justify"> Among the 252 government centres across India that monitor CD4 levels of HIV patients, the northeastern states have 17 centres. But Ahuja said the shortage has also affected some centres in New Delhi. A NACO official said patients already on anti-HIV therapy are unlikely to be affected by the shortage of CD4 testing kits because they require a test only every six months. &quot;The acute shortage is only a few days to weeks old,&quot; he said. </p>', 'credit_writer' => 'The Telegraph, 11 July, 2013, http://www.telegraphindia.com/1130711/jsp/frontpage/story_17103992.jsp#.Ud5M7qzcjco', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'northeast-hiv-tests-hit-by-reagent-hurdle-gs-mudur-21891', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 21891, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ (int) 0 => object(Cake\ORM\Entity) {}, (int) 1 => object(Cake\ORM\Entity) {}, (int) 2 => object(Cake\ORM\Entity) {} ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 21743 $metaTitle = 'LATEST NEWS UPDATES | Northeast HIV tests hit by reagent hurdle-GS Mudur' $metaKeywords = 'HIV AIDS,Health,North East' $metaDesc = ' -The Telegraph New Delhi: Patients infected with the human immuno-deficiency virus (HIV) in the northeastern states have been unable to undergo a key test required to start anti-HIV drugs for several weeks because of delays in procurement by government agencies, patient...' $disp = '<div align="justify">-The Telegraph</div><p align="justify"><br /><em>New Delhi: </em>Patients infected with the human immuno-deficiency virus (HIV) in the northeastern states have been unable to undergo a key test required to start anti-HIV drugs for several weeks because of delays in procurement by government agencies, patient interest groups said today.</p><p align="justify">The Indian Drug Users Forum said several government HIV-treatment centres across Manipur, Meghalaya, Nagaland and Tripura are facing a &quot;complete stock-out&quot; of biochemical reagents that measure levels of white blood cells called CD4 T-cells in HIV-infected persons. The CD4 levels are critical to make decisions to initiate therapy to prolong the lives of HIV patients.</p><p align="justify">Current guidelines recommend patients who have CD4 count less than 350 cells per mm should start taking the anti-HIV drugs. &quot;The stock-out keeps patients in the dark. Without CD4 counts, patients won't know when to start therapy,&quot; said Vikas Ahuja, president of the Network of Positive People.</p><p align="justify">The forum claimed that state AIDS control societies in the Northeast had written to the laboratory services division of the National AIDS Control Organisation (NACO). But none of the states have received any response despite several reminders, the forum said.</p><p align="justify">A senior NACO official told The Telegraph that procurement delays have led to the shortage of CD4 testing reagents but claimed the shortage has affected only a few HIV-treatment centres in the region. &quot;We're trying to streamline the procurement process. We've already got some deliveries and we expect all centres will have reagents in about seven to 10 days,&quot; the official said.</p><p align="justify">In a statement issued today, the network said while the Union health ministry had contracted the procurement of anti-HIV drugs and reagents for testing CD4 levels to a procurement agency, the ministry had not renewed the contract for nearly two years. It said this has led to &quot;serious delays&quot; in the procurement of CD4 testing kits for the HIV control programme. The NACO official declined to provide details of the delay in procurement but said it may have something to do with officials moving across government departments.</p><p align="justify">This poor management of the supply chain mechanism is holding up treatment for those who may urgently need to start the anti-HIV drug therapy, the forum based in Kohima said in a letter sent to NACO. Patients who have already initiated anti-HIV therapy also need to undergo CD4 counts every six months to determine the therapy is working.</p><p align="justify">&quot;It is shocking that doctors will not be able to initiate or monitor treatment of people living with HIV. This is unacceptable,&quot; Loon Gangte, a member of the Delhi Network of Positive People said in a statement this evening.</p><p align="justify">Among the 252 government centres across India that monitor CD4 levels of HIV patients, the northeastern states have 17 centres. But Ahuja said the shortage has also affected some centres in New Delhi. A NACO official said patients already on anti-HIV therapy are unlikely to be affected by the shortage of CD4 testing kits because they require a test only every six months. &quot;The acute shortage is only a few days to weeks old,&quot; he said.</p>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/northeast-hiv-tests-hit-by-reagent-hurdle-gs-mudur-21891.html"/> <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css" media="all"/> <title>LATEST NEWS UPDATES | Northeast HIV tests hit by reagent hurdle-GS Mudur | Im4change.org</title> <meta name="description" content=" -The Telegraph New Delhi: Patients infected with the human immuno-deficiency virus (HIV) in the northeastern states have been unable to undergo a key test required to start anti-HIV drugs for several weeks because of delays in procurement by government agencies, patient..."/> <script src="https://im4change.in/js/jquery-1.10.2.js"></script> <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script> <script language="javascript" type="text/javascript"> $(document).ready(function () { var img = $("img")[0]; // Get my img elem var pic_real_width, pic_real_height; $("<img/>") // Make in memory copy of image to avoid css issues .attr("src", $(img).attr("src")) .load(function () { pic_real_width = this.width; // Note: $(this).width() will not pic_real_height = this.height; // work for in memory images. }); }); </script> <style type="text/css"> @media screen { div.divFooter { display: block; } } @media print { .printbutton { display: none !important; } } </style> </head> <body> <table cellpadding="0" cellspacing="0" border="0" width="98%" align="center"> <tr> <td class="top_bg"> <div class="divFooter"> <img src="https://im4change.in/images/logo1.jpg" height="59" border="0" alt="Resource centre on India's rural distress" style="padding-top:14px;"/> </div> </td> </tr> <tr> <td id="topspace"> </td> </tr> <tr id="topspace"> <td> </td> </tr> <tr> <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> <tr> <td width="100%"> <h1 class="news_headlines" style="font-style:normal"> <strong>Northeast HIV tests hit by reagent hurdle-GS Mudur</strong></h1> </td> </tr> <tr> <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3"> <div align="justify">-The Telegraph</div><p align="justify"><br /><em>New Delhi: </em>Patients infected with the human immuno-deficiency virus (HIV) in the northeastern states have been unable to undergo a key test required to start anti-HIV drugs for several weeks because of delays in procurement by government agencies, patient interest groups said today.</p><p align="justify">The Indian Drug Users Forum said several government HIV-treatment centres across Manipur, Meghalaya, Nagaland and Tripura are facing a "complete stock-out" of biochemical reagents that measure levels of white blood cells called CD4 T-cells in HIV-infected persons. The CD4 levels are critical to make decisions to initiate therapy to prolong the lives of HIV patients.</p><p align="justify">Current guidelines recommend patients who have CD4 count less than 350 cells per mm should start taking the anti-HIV drugs. "The stock-out keeps patients in the dark. Without CD4 counts, patients won't know when to start therapy," said Vikas Ahuja, president of the Network of Positive People.</p><p align="justify">The forum claimed that state AIDS control societies in the Northeast had written to the laboratory services division of the National AIDS Control Organisation (NACO). But none of the states have received any response despite several reminders, the forum said.</p><p align="justify">A senior NACO official told The Telegraph that procurement delays have led to the shortage of CD4 testing reagents but claimed the shortage has affected only a few HIV-treatment centres in the region. "We're trying to streamline the procurement process. We've already got some deliveries and we expect all centres will have reagents in about seven to 10 days," the official said.</p><p align="justify">In a statement issued today, the network said while the Union health ministry had contracted the procurement of anti-HIV drugs and reagents for testing CD4 levels to a procurement agency, the ministry had not renewed the contract for nearly two years. It said this has led to "serious delays" in the procurement of CD4 testing kits for the HIV control programme. The NACO official declined to provide details of the delay in procurement but said it may have something to do with officials moving across government departments.</p><p align="justify">This poor management of the supply chain mechanism is holding up treatment for those who may urgently need to start the anti-HIV drug therapy, the forum based in Kohima said in a letter sent to NACO. Patients who have already initiated anti-HIV therapy also need to undergo CD4 counts every six months to determine the therapy is working.</p><p align="justify">"It is shocking that doctors will not be able to initiate or monitor treatment of people living with HIV. This is unacceptable," Loon Gangte, a member of the Delhi Network of Positive People said in a statement this evening.</p><p align="justify">Among the 252 government centres across India that monitor CD4 levels of HIV patients, the northeastern states have 17 centres. But Ahuja said the shortage has also affected some centres in New Delhi. A NACO official said patients already on anti-HIV therapy are unlikely to be affected by the shortage of CD4 testing kits because they require a test only every six months. "The acute shortage is only a few days to weeks old," he said.</p> </font> </td> </tr> <tr> <td> </td> </tr> <tr> <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> </table></body> </html>' } $cookies = [] $values = [ (int) 0 => 'text/html; charset=UTF-8' ] $name = 'Content-Type' $first = true $value = 'text/html; charset=UTF-8'header - [internal], line ?? Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181 Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55 Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141 [main] - ROOT/webroot/index.php, line 39
<head>
<link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 21743, 'title' => 'Northeast HIV tests hit by reagent hurdle-GS Mudur', 'subheading' => '', 'description' => '<div align="justify"> -The Telegraph </div> <p align="justify"> <br /> <em>New Delhi: </em>Patients infected with the human immuno-deficiency virus (HIV) in the northeastern states have been unable to undergo a key test required to start anti-HIV drugs for several weeks because of delays in procurement by government agencies, patient interest groups said today. </p> <p align="justify"> The Indian Drug Users Forum said several government HIV-treatment centres across Manipur, Meghalaya, Nagaland and Tripura are facing a "complete stock-out" of biochemical reagents that measure levels of white blood cells called CD4 T-cells in HIV-infected persons. The CD4 levels are critical to make decisions to initiate therapy to prolong the lives of HIV patients. </p> <p align="justify"> Current guidelines recommend patients who have CD4 count less than 350 cells per mm should start taking the anti-HIV drugs. "The stock-out keeps patients in the dark. Without CD4 counts, patients won't know when to start therapy," said Vikas Ahuja, president of the Network of Positive People. </p> <p align="justify"> The forum claimed that state AIDS control societies in the Northeast had written to the laboratory services division of the National AIDS Control Organisation (NACO). But none of the states have received any response despite several reminders, the forum said. </p> <p align="justify"> A senior NACO official told The Telegraph that procurement delays have led to the shortage of CD4 testing reagents but claimed the shortage has affected only a few HIV-treatment centres in the region. "We're trying to streamline the procurement process. We've already got some deliveries and we expect all centres will have reagents in about seven to 10 days," the official said. </p> <p align="justify"> In a statement issued today, the network said while the Union health ministry had contracted the procurement of anti-HIV drugs and reagents for testing CD4 levels to a procurement agency, the ministry had not renewed the contract for nearly two years. It said this has led to "serious delays" in the procurement of CD4 testing kits for the HIV control programme. The NACO official declined to provide details of the delay in procurement but said it may have something to do with officials moving across government departments. </p> <p align="justify"> This poor management of the supply chain mechanism is holding up treatment for those who may urgently need to start the anti-HIV drug therapy, the forum based in Kohima said in a letter sent to NACO. Patients who have already initiated anti-HIV therapy also need to undergo CD4 counts every six months to determine the therapy is working. </p> <p align="justify"> "It is shocking that doctors will not be able to initiate or monitor treatment of people living with HIV. This is unacceptable," Loon Gangte, a member of the Delhi Network of Positive People said in a statement this evening. </p> <p align="justify"> Among the 252 government centres across India that monitor CD4 levels of HIV patients, the northeastern states have 17 centres. But Ahuja said the shortage has also affected some centres in New Delhi. A NACO official said patients already on anti-HIV therapy are unlikely to be affected by the shortage of CD4 testing kits because they require a test only every six months. "The acute shortage is only a few days to weeks old," he said. </p>', 'credit_writer' => 'The Telegraph, 11 July, 2013, http://www.telegraphindia.com/1130711/jsp/frontpage/story_17103992.jsp#.Ud5M7qzcjco', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'northeast-hiv-tests-hit-by-reagent-hurdle-gs-mudur-21891', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 21891, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ [maximum depth reached] ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 21743, 'metaTitle' => 'LATEST NEWS UPDATES | Northeast HIV tests hit by reagent hurdle-GS Mudur', 'metaKeywords' => 'HIV AIDS,Health,North East', 'metaDesc' => ' -The Telegraph New Delhi: Patients infected with the human immuno-deficiency virus (HIV) in the northeastern states have been unable to undergo a key test required to start anti-HIV drugs for several weeks because of delays in procurement by government agencies, patient...', 'disp' => '<div align="justify">-The Telegraph</div><p align="justify"><br /><em>New Delhi: </em>Patients infected with the human immuno-deficiency virus (HIV) in the northeastern states have been unable to undergo a key test required to start anti-HIV drugs for several weeks because of delays in procurement by government agencies, patient interest groups said today.</p><p align="justify">The Indian Drug Users Forum said several government HIV-treatment centres across Manipur, Meghalaya, Nagaland and Tripura are facing a "complete stock-out" of biochemical reagents that measure levels of white blood cells called CD4 T-cells in HIV-infected persons. The CD4 levels are critical to make decisions to initiate therapy to prolong the lives of HIV patients.</p><p align="justify">Current guidelines recommend patients who have CD4 count less than 350 cells per mm should start taking the anti-HIV drugs. "The stock-out keeps patients in the dark. Without CD4 counts, patients won't know when to start therapy," said Vikas Ahuja, president of the Network of Positive People.</p><p align="justify">The forum claimed that state AIDS control societies in the Northeast had written to the laboratory services division of the National AIDS Control Organisation (NACO). But none of the states have received any response despite several reminders, the forum said.</p><p align="justify">A senior NACO official told The Telegraph that procurement delays have led to the shortage of CD4 testing reagents but claimed the shortage has affected only a few HIV-treatment centres in the region. "We're trying to streamline the procurement process. We've already got some deliveries and we expect all centres will have reagents in about seven to 10 days," the official said.</p><p align="justify">In a statement issued today, the network said while the Union health ministry had contracted the procurement of anti-HIV drugs and reagents for testing CD4 levels to a procurement agency, the ministry had not renewed the contract for nearly two years. It said this has led to "serious delays" in the procurement of CD4 testing kits for the HIV control programme. The NACO official declined to provide details of the delay in procurement but said it may have something to do with officials moving across government departments.</p><p align="justify">This poor management of the supply chain mechanism is holding up treatment for those who may urgently need to start the anti-HIV drug therapy, the forum based in Kohima said in a letter sent to NACO. Patients who have already initiated anti-HIV therapy also need to undergo CD4 counts every six months to determine the therapy is working.</p><p align="justify">"It is shocking that doctors will not be able to initiate or monitor treatment of people living with HIV. This is unacceptable," Loon Gangte, a member of the Delhi Network of Positive People said in a statement this evening.</p><p align="justify">Among the 252 government centres across India that monitor CD4 levels of HIV patients, the northeastern states have 17 centres. But Ahuja said the shortage has also affected some centres in New Delhi. A NACO official said patients already on anti-HIV therapy are unlikely to be affected by the shortage of CD4 testing kits because they require a test only every six months. "The acute shortage is only a few days to weeks old," he said.</p>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 21743, 'title' => 'Northeast HIV tests hit by reagent hurdle-GS Mudur', 'subheading' => '', 'description' => '<div align="justify"> -The Telegraph </div> <p align="justify"> <br /> <em>New Delhi: </em>Patients infected with the human immuno-deficiency virus (HIV) in the northeastern states have been unable to undergo a key test required to start anti-HIV drugs for several weeks because of delays in procurement by government agencies, patient interest groups said today. </p> <p align="justify"> The Indian Drug Users Forum said several government HIV-treatment centres across Manipur, Meghalaya, Nagaland and Tripura are facing a "complete stock-out" of biochemical reagents that measure levels of white blood cells called CD4 T-cells in HIV-infected persons. The CD4 levels are critical to make decisions to initiate therapy to prolong the lives of HIV patients. </p> <p align="justify"> Current guidelines recommend patients who have CD4 count less than 350 cells per mm should start taking the anti-HIV drugs. "The stock-out keeps patients in the dark. Without CD4 counts, patients won't know when to start therapy," said Vikas Ahuja, president of the Network of Positive People. </p> <p align="justify"> The forum claimed that state AIDS control societies in the Northeast had written to the laboratory services division of the National AIDS Control Organisation (NACO). But none of the states have received any response despite several reminders, the forum said. </p> <p align="justify"> A senior NACO official told The Telegraph that procurement delays have led to the shortage of CD4 testing reagents but claimed the shortage has affected only a few HIV-treatment centres in the region. "We're trying to streamline the procurement process. We've already got some deliveries and we expect all centres will have reagents in about seven to 10 days," the official said. </p> <p align="justify"> In a statement issued today, the network said while the Union health ministry had contracted the procurement of anti-HIV drugs and reagents for testing CD4 levels to a procurement agency, the ministry had not renewed the contract for nearly two years. It said this has led to "serious delays" in the procurement of CD4 testing kits for the HIV control programme. The NACO official declined to provide details of the delay in procurement but said it may have something to do with officials moving across government departments. </p> <p align="justify"> This poor management of the supply chain mechanism is holding up treatment for those who may urgently need to start the anti-HIV drug therapy, the forum based in Kohima said in a letter sent to NACO. Patients who have already initiated anti-HIV therapy also need to undergo CD4 counts every six months to determine the therapy is working. </p> <p align="justify"> "It is shocking that doctors will not be able to initiate or monitor treatment of people living with HIV. This is unacceptable," Loon Gangte, a member of the Delhi Network of Positive People said in a statement this evening. </p> <p align="justify"> Among the 252 government centres across India that monitor CD4 levels of HIV patients, the northeastern states have 17 centres. But Ahuja said the shortage has also affected some centres in New Delhi. A NACO official said patients already on anti-HIV therapy are unlikely to be affected by the shortage of CD4 testing kits because they require a test only every six months. "The acute shortage is only a few days to weeks old," he said. </p>', 'credit_writer' => 'The Telegraph, 11 July, 2013, http://www.telegraphindia.com/1130711/jsp/frontpage/story_17103992.jsp#.Ud5M7qzcjco', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'northeast-hiv-tests-hit-by-reagent-hurdle-gs-mudur-21891', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 21891, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ (int) 0 => object(Cake\ORM\Entity) {}, (int) 1 => object(Cake\ORM\Entity) {}, (int) 2 => object(Cake\ORM\Entity) {} ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 21743 $metaTitle = 'LATEST NEWS UPDATES | Northeast HIV tests hit by reagent hurdle-GS Mudur' $metaKeywords = 'HIV AIDS,Health,North East' $metaDesc = ' -The Telegraph New Delhi: Patients infected with the human immuno-deficiency virus (HIV) in the northeastern states have been unable to undergo a key test required to start anti-HIV drugs for several weeks because of delays in procurement by government agencies, patient...' $disp = '<div align="justify">-The Telegraph</div><p align="justify"><br /><em>New Delhi: </em>Patients infected with the human immuno-deficiency virus (HIV) in the northeastern states have been unable to undergo a key test required to start anti-HIV drugs for several weeks because of delays in procurement by government agencies, patient interest groups said today.</p><p align="justify">The Indian Drug Users Forum said several government HIV-treatment centres across Manipur, Meghalaya, Nagaland and Tripura are facing a "complete stock-out" of biochemical reagents that measure levels of white blood cells called CD4 T-cells in HIV-infected persons. The CD4 levels are critical to make decisions to initiate therapy to prolong the lives of HIV patients.</p><p align="justify">Current guidelines recommend patients who have CD4 count less than 350 cells per mm should start taking the anti-HIV drugs. "The stock-out keeps patients in the dark. Without CD4 counts, patients won't know when to start therapy," said Vikas Ahuja, president of the Network of Positive People.</p><p align="justify">The forum claimed that state AIDS control societies in the Northeast had written to the laboratory services division of the National AIDS Control Organisation (NACO). But none of the states have received any response despite several reminders, the forum said.</p><p align="justify">A senior NACO official told The Telegraph that procurement delays have led to the shortage of CD4 testing reagents but claimed the shortage has affected only a few HIV-treatment centres in the region. "We're trying to streamline the procurement process. We've already got some deliveries and we expect all centres will have reagents in about seven to 10 days," the official said.</p><p align="justify">In a statement issued today, the network said while the Union health ministry had contracted the procurement of anti-HIV drugs and reagents for testing CD4 levels to a procurement agency, the ministry had not renewed the contract for nearly two years. It said this has led to "serious delays" in the procurement of CD4 testing kits for the HIV control programme. The NACO official declined to provide details of the delay in procurement but said it may have something to do with officials moving across government departments.</p><p align="justify">This poor management of the supply chain mechanism is holding up treatment for those who may urgently need to start the anti-HIV drug therapy, the forum based in Kohima said in a letter sent to NACO. Patients who have already initiated anti-HIV therapy also need to undergo CD4 counts every six months to determine the therapy is working.</p><p align="justify">"It is shocking that doctors will not be able to initiate or monitor treatment of people living with HIV. This is unacceptable," Loon Gangte, a member of the Delhi Network of Positive People said in a statement this evening.</p><p align="justify">Among the 252 government centres across India that monitor CD4 levels of HIV patients, the northeastern states have 17 centres. But Ahuja said the shortage has also affected some centres in New Delhi. A NACO official said patients already on anti-HIV therapy are unlikely to be affected by the shortage of CD4 testing kits because they require a test only every six months. "The acute shortage is only a few days to weeks old," he said.</p>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'
include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
![]() |
Northeast HIV tests hit by reagent hurdle-GS Mudur |
-The Telegraph
The Indian Drug Users Forum said several government HIV-treatment centres across Manipur, Meghalaya, Nagaland and Tripura are facing a "complete stock-out" of biochemical reagents that measure levels of white blood cells called CD4 T-cells in HIV-infected persons. The CD4 levels are critical to make decisions to initiate therapy to prolong the lives of HIV patients. Current guidelines recommend patients who have CD4 count less than 350 cells per mm should start taking the anti-HIV drugs. "The stock-out keeps patients in the dark. Without CD4 counts, patients won't know when to start therapy," said Vikas Ahuja, president of the Network of Positive People. The forum claimed that state AIDS control societies in the Northeast had written to the laboratory services division of the National AIDS Control Organisation (NACO). But none of the states have received any response despite several reminders, the forum said. A senior NACO official told The Telegraph that procurement delays have led to the shortage of CD4 testing reagents but claimed the shortage has affected only a few HIV-treatment centres in the region. "We're trying to streamline the procurement process. We've already got some deliveries and we expect all centres will have reagents in about seven to 10 days," the official said. In a statement issued today, the network said while the Union health ministry had contracted the procurement of anti-HIV drugs and reagents for testing CD4 levels to a procurement agency, the ministry had not renewed the contract for nearly two years. It said this has led to "serious delays" in the procurement of CD4 testing kits for the HIV control programme. The NACO official declined to provide details of the delay in procurement but said it may have something to do with officials moving across government departments. This poor management of the supply chain mechanism is holding up treatment for those who may urgently need to start the anti-HIV drug therapy, the forum based in Kohima said in a letter sent to NACO. Patients who have already initiated anti-HIV therapy also need to undergo CD4 counts every six months to determine the therapy is working. "It is shocking that doctors will not be able to initiate or monitor treatment of people living with HIV. This is unacceptable," Loon Gangte, a member of the Delhi Network of Positive People said in a statement this evening. Among the 252 government centres across India that monitor CD4 levels of HIV patients, the northeastern states have 17 centres. But Ahuja said the shortage has also affected some centres in New Delhi. A NACO official said patients already on anti-HIV therapy are unlikely to be affected by the shortage of CD4 testing kits because they require a test only every six months. "The acute shortage is only a few days to weeks old," he said. |